PathAI: The three research posters demonstrate how artificial intelligence may improve the research and clinical utility of various biomarker programs Boston, MA | October 11, 2023 10:00 AM Eastern Daylight Time - PathAI, a global leader...

PathAI: The lab will support clinical trials across oncology, liver, and GI indications, with expansion to additional indications in the future.  Boston, MA – September 19, 2023 – PathAI, a global leader in AI-powered pathology,...

PathAI: AISight IMS will enable pathology labs to be at the forefront of emerging and state-of-the-art digital technologies and workflows. BOSTON — August 16, 2023 — PathAI, a global leader in AI-powered pathology, today announced the...

PathAI: Pathology market’s first algorithm to use additive multiple instance learning (aMIL) heatmaps to provide greater transparency for how AI predictions are made BOSTON — July 20, 2023 —PathAI, a leading provider of AI-powered...

PathAI IBD Explore™ panel will empower drug developers with improved inflammatory microenvironment spatial characterization from H&E, propelling a new phase of precision medicine in IBD  BOSTON — May 17, 2023 —PathAI, a global...

PathAI and ConcertAI: Researchers derive novel insights through the combination of PathAI's proprietary tumor microenvironment features with ConcertAI's multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire/ -- PathAI, a global...